Biopharmaceutical leader in the development of treatments for rare diseases
H.R.4712: Fairness in Orphan Drug Exclusivity Act.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX